Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Palliative Dehydration PDF $40.00
$40.00
× Placeholder Factors Associated With Medication Adherence in African American and White Patients With Bipolar Disorder PDF $40.00
$40.00
× Placeholder Commentary: Concerns Regarding the Inclusion of Temper Dysregulation Disorder With Dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition PDF $40.00
$40.00
× Placeholder Association Between Patient Beliefs Regarding Assigned Treatment and Clinical Response: Reanalysis of Data From the Hypericum Depression Trial Study Group PDF $40.00
$40.00
× Placeholder Toward a Definition of “No Meaningful Benefit” From Antidepressant Treatment: An Equipercentile Analysis With Cross-Trial Validation Across Multiple Rating Scales PDF $40.00
$40.00
× Placeholder Examining the Comorbidity of Bipolar Disorder and Autism Spectrum Disorders: A Large Controlled Analysis of Phenotypic and Familial Correlates in a Referred Population of Youth With Bipolar I Disorder With and Without Autism Spectrum Disorders PDF $40.00
$40.00
× Placeholder Does the Therapy Manual or the Therapist Matter Most in Treatment of Obsessive-Compulsive Disorder? A Randomized Controlled Trial of Exposure With Response or Ritual Prevention in 118 Patients PDF $40.00
$40.00
× Placeholder Divalproex Sodium in Substance Abusers With Mood Disorder. PDF $40.00
$40.00
× Placeholder Clinical Features of Depressed Children and Adolescents With Various Forms of Suicidality PDF $40.00
$40.00
× Placeholder Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis PDF $40.00
$40.00
× Placeholder "Subthreshold" Depression: Is the Distinction Between Depressive Disorder Not Otherwise Specified and Adjustment Disorder Valid? PDF $40.00
$40.00
× Placeholder Comparison of Pharmacokinetic Profiles of Brand-Name and Generic Formulations of Citalopram and Venlafaxine: A Crossover Study PDF $40.00
$40.00
× Placeholder New Coprescription of Opioids and Benzodiazepines and Mortality Among Veterans Affairs Patients With Posttraumatic Stress Disorder PDF $40.00
$40.00
× Placeholder Adherence Assessments and the Use of Depot Antipsychotics in Patients With Schizophrenia. PDF $40.00
$40.00
× Placeholder Pimavanserin: A 2019 Clarification on the FDA Update PDF $40.00
$40.00
× Placeholder Clozapine-Induced Agranulocytosis in Finland, 1982-2007: Long-Term Monitoring of Patients Is Still Warranted PDF $40.00
$40.00
× Placeholder A Survey of Sleep Quality in Patients With 13 Types of Mental Disorders PDF $40.00
$40.00
× Placeholder A Clinical Perspective of Attention-Deficit/Hyperactivity Disorder Into Adulthood PDF $40.00
$40.00
× Placeholder Cognitive Change in the Year After a First Manic Episode: Association Between Clinical Outcome and Cognitive Performance Early in the Course of Bipolar I Disorder PDF $40.00
$40.00
× Placeholder Substance Use Disorders in Individuals With Body Dysmorphic Disorder PDF $40.00
$40.00
× Placeholder Impulse-Control Disorders in a College Sample: Results From the Self-Administered Minnesota Impulse Disorders Interview (MIDI) PDF $40.00
$40.00
× Placeholder A Pilot Study of Barriers to Medication Adherence in Schizophrenia PDF $40.00
$40.00
× Placeholder Generalizability of Clinical Trial Results for Major Depression to Community Samples: Results From the National Epidemiologic Survey on Alcohol and Related Conditions PDF $40.00
$40.00
× Placeholder Comorbidity of Obsessive-Compulsive Disorder and Depression: Prevalence, Symptom Severity, and Treatment Effect PDF $40.00
$40.00
× Placeholder Delusional Misidentification Post–Traumatic Brain Injury Responding to Clozapine PDF $40.00
$40.00
× Placeholder Acute Substance Use as a Warning Sign for Suicide Attempts: A Case-Crossover Examination of the 48 Hours Prior to a Recent Suicide Attempt PDF $40.00
$40.00
× Placeholder The Diagnostic Challenge of Psychiatric Symptoms in Neurodegenerative Disease: Rates of and Risk Factors for Prior Psychiatric Diagnosis in Patients With Early Neurodegenerative Disease PDF $40.00
$40.00
× Placeholder Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $1,120.00
Total $1,120.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe